Related Experiment Video
Updated: May 3, 2026
09:51
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
11.9K
Sensing the hybrid--a novel PAMP for TLR9
Søren B Jensen1, Søren R Paludan
1Department of Biomedicine, Aarhus University, Aarhus, Denmark.
The EMBO Journal
|February 14, 2014
Summary
Toll-like receptor 9 (TLR9) typically recognizes CpG DNA. Researchers discovered that RNA-DNA hybrids are also a novel pathogen-associated molecular pattern (PAMP) recognized by TLR9 in dendritic cells.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Host immune responses rely on pattern recognition receptors (PRRs) detecting pathogen-associated molecular patterns (PAMPs).
- Toll-like receptor 9 (TLR9), abundant in plasmacytoid dendritic cells, is a known PRR for CpG DNA, triggering cytokine and type I interferon production.
Purpose of the Study:
- To identify novel PAMPs recognized by TLR9.
- To investigate the role of RNA-DNA hybrids in immune recognition by dendritic cells.
Main Methods:
- The study involved identifying ligands for TLR9.
- Experimental methods focused on dendritic cell activation and immune signaling pathways.
Main Results:
- Rigby et al. identified RNA-DNA hybrids as a novel PAMP.
- These hybrids are specifically recognized by TLR9 in dendritic cells, distinct from previously known CpG DNA.
Conclusions:
- RNA-DNA hybrids represent a newly discovered class of PAMPs.
- TLR9's recognition repertoire extends beyond DNA to include RNA-DNA hybrids, broadening our understanding of innate immunity.
Related Concept Videos
01:16Transduction
3.0K
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
3.0K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.4K
02:31In-situ Hybridization
9.2K
In situ hybridization (ISH) is a technique used to detect and localize specific DNA or RNA molecules in cells, tissue, or tissue sections using a labeled probe. The technique was first used in 1969 for the investigation of nucleic acids. It is currently an essential tool in scientific research and clinical settings, especially for diagnostic purposes.
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...
9.2K
01:31Hybridoma Technology
13.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.2K